These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28994827)

  • 1. Bladder cancer: Mastering the immune microenvironment.
    Stone L
    Nat Rev Urol; 2017 Nov; 14(11):639. PubMed ID: 28994827
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.
    Dowell AC; Cobby E; Wen K; Devall AJ; During V; Anderson J; James ND; Cheng KK; Zeegers MP; Bryan RT; Taylor GS
    PLoS One; 2017; 12(9):e0184841. PubMed ID: 28931051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux.
    Amar AD; Das S
    J Urol; 1985 Mar; 133(3):468-71. PubMed ID: 3973999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Urothelial Bladder Cancer: Predicting the Future.
    Stadler WM
    J Oncol Pract; 2019 Aug; 15(8):429-430. PubMed ID: 31404513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased risk of tumor development in the upper urinary tract following multicentric papillary bladder tumors].
    Rosenthal CL; Zingg EJ
    Urologe A; 1983 May; 22(3):183-5. PubMed ID: 6683901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?
    Dyrskjøt L
    Eur Urol; 2019 Mar; 75(3):433-434. PubMed ID: 30237022
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract.
    Chung SD
    BJU Int; 2008 Aug; 102(4):518; author reply 518-9. PubMed ID: 18699961
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research.
    Atala A
    J Urol; 2019 Oct; 202(4):664. PubMed ID: 31287759
    [No Abstract]   [Full Text] [Related]  

  • 9. Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2015 Mar; 12(3):120. PubMed ID: 25644167
    [No Abstract]   [Full Text] [Related]  

  • 10. Urothelial cancer of the urinary bladder: can lessons learned be applied to the upper urinary tract?
    Krabbe LM; Hutchinson RC; Margulis V
    Minerva Urol Nefrol; 2016 Aug; 68(4):396-408. PubMed ID: 26990295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer: Targeted agents reverse chemotherapy resistance in urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2016 Sep; 13(9):494. PubMed ID: 27480945
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunomodulatory treatment in urothelial cancer.
    Dreicer R
    Lancet Oncol; 2016 Nov; 17(11):1475-1477. PubMed ID: 27733242
    [No Abstract]   [Full Text] [Related]  

  • 13. Human urologic cancer cell lines.
    Williams RD
    Invest Urol; 1980 Mar; 17(5):359-63. PubMed ID: 6244232
    [No Abstract]   [Full Text] [Related]  

  • 14. EDITORIAL COMMENT.
    Lee BH
    Urology; 2019 Nov; 133():161-162. PubMed ID: 31706415
    [No Abstract]   [Full Text] [Related]  

  • 15. The prognostic role of stroma in UTUC.
    Masone MC
    Nat Rev Urol; 2023 Jan; 20(1):7. PubMed ID: 36477223
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomics and Therapeutic Decisions in Urothelial Malignancies.
    Vaishampayan U
    J Oncol Pract; 2019 Aug; 15(8):431-432. PubMed ID: 31404515
    [No Abstract]   [Full Text] [Related]  

  • 17. Programmed Cell Death Ligand-1 Blockade in Urothelial Bladder Cancer: To Select or Not to Select.
    Drake CG; Bivalacqua TJ; Hahn NM
    J Clin Oncol; 2016 Sep; 34(26):3115-6. PubMed ID: 27458310
    [No Abstract]   [Full Text] [Related]  

  • 18. Bending the Curve of Advanced Urothelial Carcinoma.
    Geynisman DM; Plimack ER
    J Oncol Pract; 2017 May; 13(5):319-320. PubMed ID: 28489979
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemoimmunotherapy in Metastatic Urothelial Carcinoma.
    Geynisman DM; Abbosh PH; Plimack ER; Zibelman M
    Eur Urol; 2018 May; 73(5):760-762. PubMed ID: 29331216
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary tract tumor registry].
    vom Dorp F; Börgermann C; Goebell PJ; Schmid K; Siffert W; Rettenmeier AW; Rübben H
    Urologe A; 2007 Sep; 46(9):1139-40. PubMed ID: 17641863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.